Methotrexate plus hydroxychloroquine is recommended for patients with moderate to high disease activity regardless of disease duration or poor prognostic features.

• 甲氨喋呤加羟氯喹的疗法是推荐给那些有中高度活动病情的患者，无论这些患者的病程长或短以及有无预后不良因素。